Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD.

Aboriginal and Torres Strait Islander Australians ESKD and dialysis Indigenous Australians anemia chronic kidney disease ferritin hyperferritinemia iron deficiency

Journal

Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 17 08 2020
accepted: 27 10 2020
entrez: 22 2 2021
pubmed: 23 2 2021
medline: 23 2 2021
Statut: epublish

Résumé

Aboriginal and Torres Strait Islander Australians (Indigenous Australians) suffer some of the highest rates of chronic kidney disease (CKD) in the world. Among Indigenous Australians in remote areas of the Northern Territory, prevalence rates for renal replacement therapy (RRT) are up to 30 times higher than national prevalence. Anemia among patients with CKD is a common complication. Iron deficiency is one of the major causes. Iron deficiency is also one of the key causes of poor response to the mainstay of anemia therapy with erythropoiesis-stimulating agents (ESAs). Therefore, the effective management of anemia in people with CKD is largely dependent on effective identification and correction of iron deficiency. The current identification of iron deficiency in routine clinical practice is dependent on 2 surrogate markers of iron status: serum ferritin concentration and transferrin saturation (TSAT). However, questions exist regarding the use of serum ferritin concentration in people with CKD because it is an acute-phase reactant that can be raised in the context of acute and chronic inflammation. Serum ferritin concentration among Indigenous Australians receiving RRT is often markedly elevated and falls outside reference ranges within most national and international guidelines for iron therapy for people with CKD. This review explores published data on the challenges of managing anemia in Indigenous people with CKD and the need for future research on the efficacy and safety of treatment of anemia of CKD in patients with high ferritin and evidence iron deficiency.

Identifiants

pubmed: 33615076
doi: 10.1016/j.ekir.2020.10.035
pii: S2468-0249(20)31706-X
pmc: PMC7879094
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

501-512

Informations de copyright

© 2020 International Society of Nephrology. Published by Elsevier Inc.

Références

Aust J Rural Health. 2017 Oct;25(5):285-289
pubmed: 27973736
Clin Biochem. 2017 Apr;50(6):301-308
pubmed: 27894952
Diabetes Care. 2004 Oct;27(10):2422-8
pubmed: 15451911
Heliyon. 2019 Jul 12;5(7):e02045
pubmed: 31338466
Blood Purif. 2018;45(1-3):139-146
pubmed: 30959500
Semin Hematol. 1998 Jan;35(1):35-54
pubmed: 9460808
Clin Chem. 2002 Jul;48(7):1066-76
pubmed: 12089176
Diabetes Care. 2018 Apr;41(4):739-747
pubmed: 29367427
Am J Kidney Dis. 2016 Apr;67(4):548-58
pubmed: 26763385
Clin J Am Soc Nephrol. 2009 Aug;4(8):1384-7
pubmed: 19556376
Scand J Clin Lab Invest. 2005;65(7):571-6
pubmed: 16271988
J Vasc Surg. 2010 Jun;51(6):1498-503
pubmed: 20304584
Presse Med. 2017 Dec;46(12 Pt 2):e272-e278
pubmed: 29129410
Kidney Int. 2015 Jan;87(1):162-8
pubmed: 25075769
Med Clin North Am. 2005 May;89(3):549-61
pubmed: 15755467
Trop Med Int Health. 2004 Jan;9(1):96-105
pubmed: 14728613
Hemodial Int. 2017 Jun;21 Suppl 1:S78-S82
pubmed: 28403561
Aust Health Rev. 2018 Aug;42(4):380-386
pubmed: 28553999
Biochim Biophys Acta. 2010 Aug;1800(8):760-9
pubmed: 20304033
J Am Soc Nephrol. 2007 Mar;18(3):975-84
pubmed: 17267740
PLoS One. 2018 May 3;13(5):e0196576
pubmed: 29723227
J Korean Med Sci. 2017 Feb;32(2):249-256
pubmed: 28049235
Kidney Int. 2005 Oct;68(4):1432-8
pubmed: 16164618
Clin Chem Lab Med. 2002 Apr;40(4):365-70
pubmed: 12059077
Immunol Res. 2011 May;50(1):1-9
pubmed: 21161695
Kidney Int. 2008 Nov;74(10):1237-40
pubmed: 18596731
Kidney Res Clin Pract. 2013 Mar;32(1):11-5
pubmed: 26894030
Am J Nephrol. 2018;48(4):260-268
pubmed: 30304714
Am J Kidney Dis. 1997 Dec;30(6):912-22
pubmed: 9398141
BMC Public Health. 2014 May 21;14:483
pubmed: 24884526
Presse Med. 2017 Dec;46(12 Pt 2):e279-e287
pubmed: 29133084
Kidney Int. 2006 Feb;69(3):560-4
pubmed: 16395253
Med J Aust. 1986 Jun 23;144(S2):S13-5
pubmed: 3724617
Nephrol Dial Transplant. 2013 Jun;28(6):1346-59
pubmed: 23585588
Am J Clin Nutr. 2017 Dec;106(Suppl 6):1559S-1566S
pubmed: 29070551
Nephrology (Carlton). 2016 Nov;21(11):916-922
pubmed: 27075933
BMC Nephrol. 2018 Jan 15;19(1):15
pubmed: 29334912
J Clin Med. 2019 Dec 19;9(1):
pubmed: 31861625
Am J Med. 2012 Oct;125(10):991-999.e1
pubmed: 22998881
J Am Soc Nephrol. 2012 Oct;23(10):1631-4
pubmed: 22935483
Nephrol Dial Transplant. 2002 Jun;17(6):1063-9
pubmed: 12032198
Kidney Int. 2014 Nov;86(5):867-70
pubmed: 25360487
Nephrol Dial Transplant. 1997 Jun;12(6):1173-81
pubmed: 9198047
Nephrol Dial Transplant. 2019 Mar 1;34(3):449-457
pubmed: 29390103
Br J Haematol. 2018 Mar;180(5):721-726
pubmed: 29363758
ARYA Atheroscler. 2014 Jan;10(1):32-6
pubmed: 24963311
Clin J Am Soc Nephrol. 2010 Sep;5(9):1681-9
pubmed: 20724518
Clin Kidney J. 2017 Dec;10(Suppl 1):i16-i24
pubmed: 29225819
Therap Adv Gastroenterol. 2011 May;4(3):177-84
pubmed: 21694802
Nephrology (Carlton). 2017 Feb;22(2):114-117
pubmed: 26824431
Metallomics. 2014 Apr;6(4):748-73
pubmed: 24549403
Kidney Int. 2016 Jan;89(1):28-39
pubmed: 26759045
Clin Exp Nephrol. 2018 Apr;22(2):388-394
pubmed: 28815319
N Engl J Med. 2019 Jan 31;380(5):447-458
pubmed: 30365356
Am J Nephrol. 2017;46(2):120-130
pubmed: 28704813
J Clin Endocrinol Metab. 2008 Dec;93(12):4690-6
pubmed: 18796516
Hemodial Int. 2014 Jan;18(1):38-46
pubmed: 23968235
BMC Public Health. 2011 Sep 26;11:729
pubmed: 21943132
Am J Kidney Dis. 1999 Oct;34(4 Suppl 2):S12-7
pubmed: 10516370
Clin Exp Nephrol. 2015 Oct;19(5):947-52
pubmed: 25536924
J Clin Diagn Res. 2015 Sep;9(9):BC11-3
pubmed: 26500898
Int J Clin Exp Med. 2015 Aug 15;8(8):13317-22
pubmed: 26550259
J Am Soc Nephrol. 2008 Feb;19(2):372-9
pubmed: 18216316
Clin Kidney J. 2014 Dec;7(6):524-30
pubmed: 25503952
J Paediatr Child Health. 2004 Aug;40(8):422-3
pubmed: 15265180
Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S4-8
pubmed: 17699374
EBioMedicine. 2019 Jan;39:461-471
pubmed: 30502056
Int J Nephrol. 2020 Jul 1;2020:7692376
pubmed: 32665863
PLoS One. 2014 Jan 02;9(1):e84943
pubmed: 24392162
Presse Med. 2017 Dec;46(12 Pt 2):e306-e311
pubmed: 29169710
EBioMedicine. 2019 Feb;40:31-32
pubmed: 30660656
Aust J Rural Health. 2013 Oct;21(5):268-73
pubmed: 24118149
Hemodial Int. 2017 Jun;21 Suppl 1:S21-S27
pubmed: 28328097
BMC Infect Dis. 2012 Oct 09;12:249
pubmed: 23043704
Atherosclerosis. 2002 Nov;165(1):179-84
pubmed: 12208485
Obes Rev. 2009 May;10(3):255-61
pubmed: 19207873
Adv Chronic Kidney Dis. 2005 Jan;12(1):39-48
pubmed: 15719332
Presse Med. 2017 Dec;46(12 Pt 2):e329-e338
pubmed: 29150231
Hemodial Int. 2017 Jun;21 Suppl 1:S58-S67
pubmed: 28328144
Clin J Am Soc Nephrol. 2019 May 7;14(5):728-737
pubmed: 30988164
Am J Kidney Dis. 2018 Mar;71(3):423-435
pubmed: 29336855
Kidney Int. 2014 Oct;86(4):845-54
pubmed: 24759150
N Engl J Med. 2013 Jan 24;368(4):387-9
pubmed: 23343068
PLoS One. 2015 Jul 16;10(7):e0132006
pubmed: 26182077
Nephrology (Carlton). 2017 Sep;22(9):699-705
pubmed: 27312245
Am J Kidney Dis. 2013 Nov;62(5):860-73
pubmed: 24054466
Hemodial Int. 2014 Oct;18(4):740-50
pubmed: 24766376
Innate Immun. 2015 Jul;21(5):523-30
pubmed: 25432967
Hematology. 2004 Oct-Dec;9(5-6):339-50
pubmed: 15763972
Int J Cardiol. 2014 May 1;173(2):190-6
pubmed: 24613366
Int J Nephrol. 2017;2017:5490963
pubmed: 28243472
Nephrol Dial Transplant. 2014 Feb;29(2):255-9
pubmed: 24166458
Med J Aust. 2010 Nov 1;193(9):525-32
pubmed: 21034387
Kidney Int Rep. 2017 Sep 20;3(1):160-167
pubmed: 29340327
Semin Dial. 2014 Jan-Feb;27(1):26-36
pubmed: 24329610
Med J Aust. 1997 Mar 3;166(5):241-4
pubmed: 9076267
Nephrology (Carlton). 2013 Dec;18(12):747-9
pubmed: 23879376
PLoS One. 2008;3(10):e3547
pubmed: 18958176
Blood Purif. 2016;42(1):56-63
pubmed: 27093060
BMJ. 2015 Jun 04;350:h2258
pubmed: 26044132
J Am Soc Nephrol. 2002 Mar;13(3):734-44
pubmed: 11856779
Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S9-18
pubmed: 17699375

Auteurs

Sandawana William Majoni (SW)

Department of Nephrology, Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Flinders University and Northern Territory Medical Program, Royal Darwin Hospital Campus, Darwin, Northern Territory, Australia.
Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.

Paul D Lawton (PD)

Department of Nephrology, Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.

Geetha Rathnayake (G)

Flinders University and Northern Territory Medical Program, Royal Darwin Hospital Campus, Darwin, Northern Territory, Australia.
Chemical Pathology-Territory Pathology, Department of Health, Northern Territory Government, Northern Territory, Australia.

Federica Barzi (F)

Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.

Jaquelyne T Hughes (JT)

Department of Nephrology, Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.

Alan Cass (A)

Wellbeing and Preventable Chronic Diseases, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia.

Classifications MeSH